You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
The drugmaker has partnered with Inspire and others to find study participants who have a genetic resilience to lung cancer.
FoundationOne Liquid CDx can now be used as a companion diagnostic for therapies to treat advanced ovarian, breast, and non-small cell lung cancer.
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
The two companies will create a platform that combines drug screening services and cancer genomic profiling to help oncologists choose the right treatment for their patients.
The INTERCEPT study showed the potential of broader genetic testing to personalize treatment approaches for cancer patients.
A Phase I study used a less toxic dosing schedule that yielded encouraging response rates in patients with difficult-to-treat KRAS-mutated cancers.